• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 mA 调节子的甲基化修饰模式,其特征在于结肠癌中具有不同的肿瘤微环境免疫特征。

mA regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer.

机构信息

Department of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China.

Department of Gastrointestinal Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250021, China.

出版信息

Theranostics. 2021 Jan 1;11(5):2201-2217. doi: 10.7150/thno.52717. eCollection 2021.

DOI:10.7150/thno.52717
PMID:33500720
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7797678/
Abstract

Recent studies have highlighted the biological significance of RNA N-methyladenosine (mA) modification in tumorigenicity and progression. However, it remains unclear whether mA modifications also have potential roles in immune regulation and tumor microenvironment (TME) formation. : In this study, we curated 23 mA regulators and performed consensus molecular subtyping with NMF algorithm to determine mA modification patterns and the mA-related gene signature in colon cancer (CC). The ssGSEA and CIBERSORT algorithms were employed to quantify the relative infiltration levels of various immune cell subsets. An PCA algorithm based mSig scoring scheme was used to evaluate the mA modification patterns of individual tumors with an immune response. : Three distinct m6A modification patterns were identified among 1307 CC samples, which were also associated with different clinical outcomes and biological pathways. The TME characterization revealed that the identified mA patterns were highly consistent with three known immune profiles: immune-inflamed, immune-excluded, and immune-desert, respectively. Based on the mSig score, which was extracted from the mA-related signature genes, CC patients can be divided into high and low score subgroups. Patients with lower mSig score was characterized by prolonged survival time and enhanced immune infiltration. Further analysis indicated that lower mSig score also correlated with greater tumor mutation loads, PD-L1 expression, and higher mutation rates in SMGs (e.g., and ). In addition, patients with lower mSig scores showed a better immune responses and durable clinical benefits in three independent immunotherapy cohorts. : This study highlights that mA modification is significantly associated with TME diversity and complexity. Quantitatively evaluating the mA modification patterns of individual tumors will strengthen our understanding of TME characteristics and promote more effective immunotherapy strategies.

摘要

最近的研究强调了 RNA N6-甲基腺苷(m6A)修饰在肿瘤发生和进展中的生物学意义。然而,m6A 修饰是否也在免疫调节和肿瘤微环境(TME)形成中具有潜在作用仍不清楚。

在这项研究中,我们整理了 23 个 m6A 调节剂,并使用 NMF 算法进行共识分子亚型分析,以确定结肠癌(CC)中的 m6A 修饰模式和 m6A 相关基因特征。ssGSEA 和 CIBERSORT 算法用于量化各种免疫细胞亚群的相对浸润水平。基于 PCA 算法的 mSig 评分方案用于评估具有免疫反应的个体肿瘤的 m6A 修饰模式。

在 1307 个 CC 样本中鉴定出三种不同的 m6A 修饰模式,它们也与不同的临床结局和生物学途径相关。TME 特征分析表明,鉴定出的 m6A 模式与三种已知的免疫特征高度一致,分别为免疫激活、免疫排斥和免疫荒漠。基于从 m6A 相关特征基因中提取的 mSig 评分,CC 患者可分为高和低评分亚组。mSig 评分较低的患者具有更长的生存时间和增强的免疫浸润。进一步分析表明,mSig 评分较低还与更高的肿瘤突变负荷、PD-L1 表达和 SMGs(如 和 )中的更高突变率相关。此外,mSig 评分较低的患者在三个独立的免疫治疗队列中表现出更好的免疫反应和持久的临床获益。

这项研究强调了 m6A 修饰与 TME 多样性和复杂性显著相关。定量评估个体肿瘤的 m6A 修饰模式将加强我们对 TME 特征的理解,并促进更有效的免疫治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a6c/7797678/3df961c6c38a/thnov11p2201g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a6c/7797678/904a98cfb632/thnov11p2201g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a6c/7797678/4e25b7e89b47/thnov11p2201g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a6c/7797678/27fac56788e0/thnov11p2201g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a6c/7797678/eccc253b00b9/thnov11p2201g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a6c/7797678/8feb55c86614/thnov11p2201g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a6c/7797678/3df961c6c38a/thnov11p2201g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a6c/7797678/904a98cfb632/thnov11p2201g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a6c/7797678/4e25b7e89b47/thnov11p2201g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a6c/7797678/27fac56788e0/thnov11p2201g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a6c/7797678/eccc253b00b9/thnov11p2201g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a6c/7797678/8feb55c86614/thnov11p2201g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a6c/7797678/3df961c6c38a/thnov11p2201g006.jpg

相似文献

1
mA regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer.基于 mA 调节子的甲基化修饰模式,其特征在于结肠癌中具有不同的肿瘤微环境免疫特征。
Theranostics. 2021 Jan 1;11(5):2201-2217. doi: 10.7150/thno.52717. eCollection 2021.
2
Comprehensive analysis of mA regulator-based methylation modification patterns characterized by distinct immune profiles in colon adenocarcinomas.基于 mA 调节剂的甲基化修饰模式的综合分析,其特征在于结肠腺癌中不同的免疫特征。
Gene. 2022 May 5;821:146250. doi: 10.1016/j.gene.2022.146250. Epub 2022 Feb 10.
3
mA regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer.mA 调节剂介导的甲基化修饰模式及胃癌肿瘤微环境浸润特征。
Mol Cancer. 2020 Mar 12;19(1):53. doi: 10.1186/s12943-020-01170-0.
4
The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer.m6A RNA 甲基化修饰在宫颈癌预后和肿瘤微环境免疫浸润中的意义。
Medicine (Baltimore). 2022 Jul 1;101(26):e29818. doi: 10.1097/MD.0000000000029818.
5
Comprehensive landscape of m6A regulator-related gene patterns and tumor microenvironment infiltration characterization in gastric cancer.胃癌中 m6A 调节因子相关基因模式的综合全景和肿瘤微环境浸润特征分析。
Sci Rep. 2024 Jul 16;14(1):16404. doi: 10.1038/s41598-024-66744-0.
6
Identification of mA Regulator-Associated Methylation Modification Clusters and Immune Profiles in Melanoma.黑色素瘤中与mA调节因子相关的甲基化修饰簇及免疫特征的鉴定
Front Cell Dev Biol. 2021 Dec 21;9:761134. doi: 10.3389/fcell.2021.761134. eCollection 2021.
7
mA Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Pancreatic Cancer.mA 甲基化修饰模式与胰腺癌肿瘤微环境浸润特征。
Front Immunol. 2021 Sep 20;12:739768. doi: 10.3389/fimmu.2021.739768. eCollection 2021.
8
m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.m6A 调节子介导的甲基化修饰模式及肝癌肿瘤微环境浸润特征
Aging (Albany NY). 2021 Aug 30;13(16):20698-20715. doi: 10.18632/aging.203456.
9
Correlation analysis of m6A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma.肺腺癌中 m6A 修饰调节因子与免疫微环境浸润细胞的相关性分析。
PLoS One. 2022 Feb 23;17(2):e0264384. doi: 10.1371/journal.pone.0264384. eCollection 2022.
10
Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.基于 m6A RNA 甲基化修饰和免疫微环境的肺腺癌分子亚型特征。
BMC Cancer. 2021 Aug 20;21(1):938. doi: 10.1186/s12885-021-08655-1.

引用本文的文献

1
A Study to Evaluate the Potential Role and Clinical Application Value of Long Noncoding RNA CASC Family Members in Colorectal Cancer Based on Transcriptomic Data.基于转录组数据评估长链非编码RNA CASC家族成员在结直肠癌中的潜在作用及临床应用价值的研究
Int J Genomics. 2025 Jul 24;2025:3881424. doi: 10.1155/ijog/3881424. eCollection 2025.
2
Cross-talk of mA methylation modification and the tumor microenvironment composition in esophageal cancer.食管癌中mA甲基化修饰与肿瘤微环境组成的相互作用
Front Immunol. 2025 Jul 7;16:1572810. doi: 10.3389/fimmu.2025.1572810. eCollection 2025.
3
Correlation analysis of mitochondrial DNA maintenance-related genes with HCC prognosis, tumor mutation burden and tumor microenvironment features.

本文引用的文献

1
Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer.鉴定预测结肠癌预后风险和淋巴细胞浸润的免疫特征。
Front Immunol. 2020 Sep 3;11:1678. doi: 10.3389/fimmu.2020.01678. eCollection 2020.
2
Age-related mutational signature negatively associated with immune activity and survival outcome in triple-negative breast cancer.与年龄相关的突变特征与三阴性乳腺癌的免疫活性和生存结果呈负相关。
Oncoimmunology. 2020 Jun 30;9(1):1788252. doi: 10.1080/2162402X.2020.1788252.
3
mA RNA modification modulates PI3K/Akt/mTOR signal pathway in Gastrointestinal Cancer.
线粒体DNA维持相关基因与肝癌预后、肿瘤突变负荷及肿瘤微环境特征的相关性分析
PLoS One. 2025 Jun 2;20(6):e0325033. doi: 10.1371/journal.pone.0325033. eCollection 2025.
4
Pan-cancer analysis of DLAT reveals it as a prognostic Biomarker involved in immune infiltration of liver hepatocellular carcinoma.DLAT的泛癌分析表明其作为一种预后生物标志物参与肝细胞癌的免疫浸润。
J Cancer. 2025 Mar 21;16(7):2167-2180. doi: 10.7150/jca.102256. eCollection 2025.
5
Revealing tumor microenvironment communication through m6A single-cell analysis and elucidating immunotherapeutic potentials for cutaneous melanoma (CM).通过m6A单细胞分析揭示肿瘤微环境通讯并阐明皮肤黑色素瘤(CM)的免疫治疗潜力。
J Cancer Res Clin Oncol. 2025 Apr 9;151(4):135. doi: 10.1007/s00432-025-06176-z.
6
Molecular characteristics and cancer immunity of LRP1B and its relationship with the Hedgehog signaling pathway in colorectal cancer.LRP1B在结直肠癌中的分子特征、癌症免疫及其与刺猬信号通路的关系
Front Immunol. 2025 Mar 18;16:1567102. doi: 10.3389/fimmu.2025.1567102. eCollection 2025.
7
Spatial Metabolomics and Transcriptomics Reveal Metabolic Reprogramming and Cellular Interactions in Nasopharyngeal Carcinoma with High PD-1 Expression and Therapeutic Response.空间代谢组学和转录组学揭示了高PD-1表达及治疗反应的鼻咽癌中的代谢重编程和细胞间相互作用。
Theranostics. 2025 Feb 10;15(7):3035-3054. doi: 10.7150/thno.102822. eCollection 2025.
8
Comprehensive microarray analysis for the identification of therapeutic targets within HIF-1α signalling networks in diet-induced obesity via hypothalamic inflammation.通过下丘脑炎症对饮食诱导肥胖中HIF-1α信号网络内治疗靶点进行鉴定的综合微阵列分析。
Arch Endocrinol Metab. 2025 Mar 10;69(1):e240098. doi: 10.20945/2359-4292-2024-0098.
9
The m6A revolution: transforming tumor immunity and enhancing immunotherapy outcomes.m6A革命:重塑肿瘤免疫并改善免疫治疗效果
Cell Biosci. 2025 Feb 22;15(1):27. doi: 10.1186/s13578-025-01368-z.
10
Multi-Omics Analysis Reveals Immune Infiltration and Clinical Significance of Phosphorylation Modification Enzymes in Lung Adenocarcinoma.多组学分析揭示肺腺癌中磷酸化修饰酶的免疫浸润及临床意义
Int J Mol Sci. 2025 Jan 26;26(3):1066. doi: 10.3390/ijms26031066.
mA RNA 修饰调控胃肠癌中的 PI3K/Akt/mTOR 信号通路。
Theranostics. 2020 Jul 25;10(21):9528-9543. doi: 10.7150/thno.42971. eCollection 2020.
4
Roles of long non-coding RNAs and emerging RNA-binding proteins in innate antiviral responses.长非编码 RNA 和新兴 RNA 结合蛋白在先天抗病毒反应中的作用。
Theranostics. 2020 Jul 23;10(20):9407-9424. doi: 10.7150/thno.48520. eCollection 2020.
5
METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications.METTL14 通过增加 FOXO1 N6-甲基腺苷修饰加剧内皮炎症和动脉粥样硬化。
Theranostics. 2020 Jul 11;10(20):8939-8956. doi: 10.7150/thno.45178. eCollection 2020.
6
ALKBH5 suppresses malignancy of hepatocellular carcinoma via mA-guided epigenetic inhibition of LYPD1.ALKBH5 通过 mA 引导的 LYPD1 表观遗传抑制抑制肝癌的恶性程度。
Mol Cancer. 2020 Aug 10;19(1):123. doi: 10.1186/s12943-020-01239-w.
7
Macrophage correlates with immunophenotype and predicts anti-PD-L1 response of urothelial cancer.巨噬细胞与免疫表型相关,并可预测尿路上皮癌对 PD-L1 抗体的反应。
Theranostics. 2020 May 25;10(15):7002-7014. doi: 10.7150/thno.46176. eCollection 2020.
8
RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.RNA 去甲基酶 ALKBH5 通过 m6A-YTHDF2 依赖的方式在后转录水平激活 PER1 来阻止胰腺癌细胞的进展。
Mol Cancer. 2020 May 19;19(1):91. doi: 10.1186/s12943-020-01158-w.
9
The potential role of RNA N6-methyladenosine in Cancer progression.RNA N6-甲基腺苷在癌症进展中的潜在作用。
Mol Cancer. 2020 May 12;19(1):88. doi: 10.1186/s12943-020-01204-7.
10
The RNA modification N-methyladenosine as a novel regulator of the immune system.RNA 修饰 N6-甲基腺苷作为免疫系统的新型调节剂。
Nat Immunol. 2020 May;21(5):501-512. doi: 10.1038/s41590-020-0650-4. Epub 2020 Apr 13.